Axsome Therapeutics (AXSM) Share-based Compensation Growth (5y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.42% |
| Dec 31, 2025 | 32.31% |
| Sep 30, 2025 | 51.77% |
| Jun 30, 2025 | 80.07% |
| Mar 31, 2025 | 61.32% |
| Dec 31, 2024 | 50.86% |
| Sep 30, 2024 | 79.68% |
| Jun 30, 2024 | 88.92% |
| Mar 31, 2024 | 74.26% |
| Dec 31, 2023 | 121.71% |
| Sep 30, 2023 | 110.86% |
| Jun 30, 2023 | 101.89% |
| Mar 31, 2023 | 89.15% |
| Dec 31, 2022 | 134.04% |
| Sep 30, 2022 | -52.69% |
| Jun 30, 2022 | -53.82% |
| Mar 31, 2022 | -59.10% |
| Dec 31, 2021 | 68.42% |
| Sep 30, 2021 | 65.69% |
| Jun 30, 2021 | 62.47% |
| Mar 31, 2021 | 41.57% |
| Dec 31, 2020 | 98.40% |
| Sep 30, 2020 | 51.39% |
| Jun 30, 2020 | 47.63% |
| Mar 31, 2020 | 95.47% |